Search
ATAI Life Sciences NV
ATAIAdd to Watchlist
7.180USD
0.0000.00%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.66BMarket Cap
LossP/E TTM
More Details of ATAI Life Sciences NV Company
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
ATAI Life Sciences NV Info
Ticker SymbolATAI
Company nameAtai Beckley NV
IPO dateJun 18, 2021
CEORao (Srinivas G)
Number of employees54
Security typeOrdinary Share
Fiscal year-endJun 18
AddressProf. J.H.Bavincklaan 7
CityAMSTELVEEN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryNetherlands
Postal code1183 AT
Phone31207932536
Websitehttps://www.atai.com/
Ticker SymbolATAI
IPO dateJun 18, 2021
CEORao (Srinivas G)
Company Executives of ATAI Life Sciences NV
Name
Name/Position
Position
Shareholding
Change
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Ms. Anne Johnson
Ms. Anne Johnson
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gerd G. Kochendoerfer
Dr. Gerd G. Kochendoerfer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kevin James Craig, M.D.
Dr. Kevin James Craig, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Scott N. Braunstein, M.D.
Dr. Scott N. Braunstein, M.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
FAQs
Who are the top five shareholders of ATAI Life Sciences NV?
The top five shareholders of ATAI Life Sciences NV are: Dr. Glenn Frank Short, Ph.D.
How many institutions hold shares of ATAI Life Sciences NV (ATAI)?
As of 2026Q1, 296 institutions hold shares of ATAI Life Sciences NV, with a combined market value of approximately 73.07M, accounting for 19.93% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 23428346.00.